588 related articles for article (PubMed ID: 28287667)
21. Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study.
Dömötör O; Enyedy ÉA
J Biol Inorg Chem; 2019 Aug; 24(5):703-719. PubMed ID: 31300922
[TBL] [Abstract][Full Text] [Related]
22. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
23. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
[TBL] [Abstract][Full Text] [Related]
24. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
[TBL] [Abstract][Full Text] [Related]
25. Comparative solution equilibrium studies on pentamethylcyclopentadienyl rhodium complexes of 2,2'-bipyridine and ethylenediamine and their interaction with human serum albumin.
Enyedy ÉA; Mészáros JP; Dömötör O; Hackl CM; Roller A; Keppler BK; Kandioller W
J Inorg Biochem; 2015 Nov; 152():93-103. PubMed ID: 26364131
[TBL] [Abstract][Full Text] [Related]
26. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
Bhattacharyya S; Purkait K; Mukherjee A
Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
[TBL] [Abstract][Full Text] [Related]
27. Self-Assembly of Discrete Ru
Ajibola Adeyemo A; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
Inorg Chem; 2017 Jan; 56(1):608-617. PubMed ID: 27997153
[TBL] [Abstract][Full Text] [Related]
28. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
30. Comparative solution equilibrium studies of anticancer gallium(III) complexes of 8-hydroxyquinoline and hydroxy(thio)pyrone ligands.
Enyedy ÉA; Dömötör O; Varga E; Kiss T; Trondl R; Hartinger CG; Keppler BK
J Inorg Biochem; 2012 Dec; 117():189-97. PubMed ID: 23089600
[TBL] [Abstract][Full Text] [Related]
31. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG
Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616
[TBL] [Abstract][Full Text] [Related]
32. Half-sandwich complexes of rhodium containing cysteine-derived ligands.
Carmona M; Rodríguez R; Lahoz FJ; García-Orduña P; Osante I; Cativiela C; López JA; Carmona D
Dalton Trans; 2016 Sep; 45(36):14203-15. PubMed ID: 27533899
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic Ru
Sarkar A; Acharya S; Khushvant K; Purkait K; Mukherjee A
Dalton Trans; 2019 May; 48(21):7187-7197. PubMed ID: 30601545
[TBL] [Abstract][Full Text] [Related]
34. Anticancer Ru(η
Arshad J; Hanif M; Movassaghi S; Kubanik M; Waseem A; Söhnel T; Jamieson SMF; Hartinger CG
J Inorg Biochem; 2017 Dec; 177():395-401. PubMed ID: 28916262
[TBL] [Abstract][Full Text] [Related]
35. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
[TBL] [Abstract][Full Text] [Related]
36. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
[TBL] [Abstract][Full Text] [Related]
37. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
38. Biological studies of chalcogenolato-bridged dinuclear half-sandwich complexes.
Johnpeter JP; Gupta G; Kumar JM; Srinivas G; Nagesh N; Therrien B
Inorg Chem; 2013 Dec; 52(23):13663-73. PubMed ID: 24245963
[TBL] [Abstract][Full Text] [Related]
39. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
[TBL] [Abstract][Full Text] [Related]
40. Rhodium(III) Dihalido Complexes: The Effect of Ligand Substitution and Halido Coordination on Increasing Cancer Cell Potency.
Lord RM; Zegke M; Basri AM; Pask CM; McGowan PC
Inorg Chem; 2021 Feb; 60(3):2076-2086. PubMed ID: 33463147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
